Serum paraoxonase as an indicator for fatty liver in sheep

Open access


Introduction: A model of fatty liver in postpartum sheep was established to measure blood paraoxonase 1 (PON1) and other biochemical indicators, which were used to predict fatty liver in sheep.

Material and Methods: Sheep were assigned into two experimental groups: a fatty liver group (T, n = 10) and a healthy control group (C, n = 5). PON1 enzyme activity towards paraoxon as a substrate was quantified spectrophotometrically. The results were analysed by t-test and pearson correlation coefficient. Disease was predicted by binary logistic analysis, and diagnostic thresholds were determined by receiver operatingcharacteristic (ROC) analysis.

Results: The activity of serum PON1 in group T was significantly decreased (P < 0.05) when compared with C group, and liver lipid content and the levels of serum BHBA, NEFA, and TG were significantly increased (P < 0.05). Thresholds were lower than 74.0 U/mL for PON1, higher than 0.97 mmol/L for β-hydroxybutyrate, higher than 1.29 mmol/L for non-esterified fatty acids, higher than 0.24 mmol/L for triglycerides, and lower than 71.35 g/L for total protein.

Conclusion: This study verified that PON1, BHBA, NEFA, TG, and TP could be used to predict the risk of fatty liver in sheep.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Adams L.A. Lindor K.D.: Nonal coholic fatty liver disease. Ann Epidemiol 2007 17 863–869.

  • 2. Ahlfors C.E.: Predicting bilirubin neurotoxicity in jaundiced newborns. Curr Opin Pediatr 2010 22 129–133.

  • 3. AI-Qudah K.M.: Oxidant and antioxidant profile of hyperketonemic ewes affected by pregnancy toxemia. Vet Clin Path 2011 40 60–65.

  • 4. Aviram M. Rosenblat M.: Paraoxonases 1 2 and 3 oxidative stress and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004 37 1304–1316.

  • 5. Aviram M. Rosenblat M.: Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 2005 16 393–399.

  • 6. Başoğlu A. Sevinç M. Mahmut O.K. Gökçen M.: Peri and postparturient concentrations of lipid lipoprotein insulin and glucose in normal dairy cows. Turk J Vet Anim Sci 1998 22 141–144.

  • 7. Bobe G. Young J.W. Beitz D.C.: Invited review: pathology etiology prevention and treatment of fatty liver in dairy cows. J Dairy Sci 2004 87 3105–3124.

  • 8. Bouwstra R. Goselink R. Dobbelaar P. Nielen M. Newbold J. Van Werven T.: The relationship between oxidative damage and vitamin E concentration in blood milk and liver tissue from vitamin E supplemented and nonsupplemented periparturient heifers. J Dairy Sci 2008 91 977–987.

  • 9. Cal L. Borteiro C. Benech A. Rodas E. Abreu M.N. Cruz J.C. González Montaña J.R.: Histological changes of the liver and metabolic correlates in ewes with pregnancy toxemia. Arq Bras Med Vet Zootec 2009 61 306–312.

  • 10. Christie W.W. Noble R.C. Clegg R.A.: The hydrolysis of very low density lipoproteins and chylomicrons of intestinal origin by lipoprotein lipase in ruminants. Lipids 1986 21 252–253.

  • 11. Farid A.S. Honkawa K. Fath E.M. Nonaka N. Horii Y.: Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows. BMC Vet Res 2013 9 1.

  • 12. Gan K.N. Smolen A. Eckerson H.W. La Du B.N.: Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991 19 100–106.

  • 13. Gutteridge J.M.: Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995 41 1819–1828.

  • 14. Helman R.G. Adams L.G. Bridges C.H.: The lesions of hepatic fatty cirrhosis in sheep. Vet Pathol 1995 32 635–640.

  • 15. Herdt T. Wensing T. Haagsman H.P. Van Golde L.M.G. Breukink H.J.: Hepatic triacylglycerol synthesis during a period of fatty liver development in sheep. J Anim Sci 1988 66 1997–2013.

  • 16. Jain S.K. McVie R. Bocchini J.A.: Hyperketonemia (ketosis) oxidative stress and type 1 diabetes. Pathophysiology 2006 13 163–170.

  • 17. Mackness M.I. Mackness B. Durrington P.N. Connelly P.W. Hegele R.A.: Paraoxonase: biochemistry genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996 7 69–76.

  • 18. Ostrow J.D. Pascolo L. Shapiro S.M. Tiribelli C.: New concepts in bilirubin encephalopathy. Eur J Clin Invest 2003 33 988–997.

  • 19. Pessayre D. Mansouri A. Haouzi D. Fromenty B.: Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999 15 367–373.

  • 20. Reichel J. Hänsel W. Hänsch T.W.: Atomic micromanipulation with magnetic surface traps. Phys Rev Lett 1999 83 3398.

  • 21. Reid R.L. Hinks N.T.: Studies on the carbohydrate metabolism of sheep. XVIII. The metabolism of glucose free fatty acids ketones and amino acids in late pregnancy and lactation. Crop Pasture Sci 1962 13 1112–1123.

  • 22. Sahoo S.S. Patra R.C. Behera P.C. Swarup D.: Oxidative stress indices in the erythrocytes from lactating cows after treatment for subclinical ketosis with antioxidant incorporated in the therapeutic regime. Vet Res Commun 2009 33 281–290.

  • 23. Seifi H.A. Gorji-Dooz M. Mohri M. Dalir-Naghadeh B. Farzaneh N.: Variations of energy-related biochemical metabolites during transition period in dairy cows. Com Clin Pathol 2007 16 253–258.

  • 24. Soran H. Schofield J.D. Durrington P.N.: Antioxidant properties of HDL. Front Pharmacol 2015 6 222–222.

  • 25. Videla L.A.: Energy metabolism thyroid calorigenesis and oxidative stress: functional and cytotoxic consequences. Redox Rep 2000 5 265–275.

Journal information
Impact Factor

IMPACT FACTOR J Vet Res 2018: 0.829
5-year IMPACT FACTOR: 0.938

CiteScore 2018: 0.68

SCImago Journal Rank (SJR) 2018: 0.291
Source Normalized Impact per Paper (SNIP) 2018: 0.501

Cited By
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1508 1070 17
PDF Downloads 1639 1203 2